Verastem Oncology (VSTM) Misses Q4 EPS by 50c
Get Alerts VSTM Hot Sheet
Join SI Premium – FREE
Verastem Oncology (NASDAQ: VSTM) reported Q4 EPS of ($0.50). Revenue for the quarter came in at $17.54 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Walmart will be lowering prices
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Barclays Downgrades Siemens Energy AG (ENR:GR) (SMEGF) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share